Tarrytown, NY and New York, NY, Dec. 27, 2023 Visiox Pharmaceuticals, Inc. , a commercial-stage biopharmaceutical company, and PowerUp Acquisition Corp. today announced the execution of a.
DelveInsight s, Glaucoma Pipeline Insight 2023 report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in the Glaucoma pipeline landscape. It covers the Glaucoma pipeline.
Visiox Pharma acquires licensing rights for Omlonti in US healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Visiox Pharma, Inc., a privately funded biopharmaceutical company focused on the development and commercialization of ophthalmic drugs to.
/PRNewswire/ Visiox Pharmaceuticals, Inc., a privately funded biopharmaceutical company focused on the development and commercialization of ophthalmic drugs.